Weed

BUDZ · OTC

$0.0179−$0.0001 (−0.56%)TodayMarket closed ·
Prev close $0.018

About BUDZ

WEED, Inc. operates as a holding company, which engages on the development and application of cannabis-derived compounds for the treatment of human disease. The company is headquartered in Tucson, Arizona and currently employs 2 full-time employees. The company went IPO on 2010-11-10. The firm and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. The Company, through its subsidiary, Sangre AT, LLC, doing business as Sangre AgroTech, is engaged in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry. Its other subsidiaries include WEED Israel Cannabis Ltd, WEED Australia Ltd, and others.

Employees
2
Headquarters
Tucson, Arizona
Listed
Nov 10, 2010
Sector
Health Care
Industry
Pharmaceuticals

BUDZ key statistics

Market cap
2.65M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
64.24K
Volume
118.41K
Open price
$0.018
High today
$0.019
Low today
$0.0179
52 Week high
$0.0848
52 Week low
$0.0159

Weed (BUDZ) at a glance

Weed (BUDZ) last traded at $0.0179, with a market cap of 2.65M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.0179 and $0.019. The current price is 0.0% above the day's low and 5.8% below its high.

Volume so far is 118.41K shares, above the average of 64.24K shares a day.

Over the past year Weed has ranged from $0.0159 to $0.0848, and now sits 3% of the way up that range.

BUDZ news

  • Press releaseACCESS Newswire

    WEED, Inc. (OTCQB:BUDZ) Unveils 2026 Growth Vision Combining Cannabis Operations, Proprietary Genetics, and Digital Asset Innovation

  • Press releaseACCESS Newswire

    BUDZ Highlights Valuable Legacy Genetics Portfolio Following Historic Federal Schedule III Marijuana Action WEED Inc. (OTCQB:BUDZ) Positioned with Rare Landrace Strains as DOJ Announces Immediate Schedule III Pathway for Qualified Medical Marijuana Products

  • Press releaseACCESS Newswire

    WEED Inc. Engages Advisors to Evaluate Strategic Alternatives for Sugar Hill Asset and Broader Corporate Platform

  • Press releaseACCESS Newswire

    WEED Inc (OTCQB:BUDZ) Looks to Advance a High-Value AI Data Center Opportunity for The Four Winds of Lake Erie, LLC. On Our Prime Lake Erie Waterfront Property

  • Press releaseACCESS Newswire

    WEED Inc. Forms Strategic Partnership with Remergify Inc. to Design, Develop, Program, Deploy & Coordinate the Launch of WEEDCoin & BUDZCoin in the AI/Crypto/Blockchain Universe

  • Press releaseGlobe Newswire

    WEED Inc. President and CEO Releases Letter to Shareholders

Similar companies

Companies in the same industry as Weed

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.